DOWAY (Defeng Solife Holdings) Research & Development: $0.00 Mil (TTM As of Dec. 2025)


DOWAY Defeng Solife Holdings Ltd DOWAY
34 GF Score
Price $0.75
GF Value $1.35
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is Defeng Solife Holdings Research & Development?

Defeng Solife Holdings DOWAY 34 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates DOWAY with a GF Score™ of 34/100 and a GF Value™ of $1.35 (Possible Value Trap). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Defeng Solife Holdings's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

Defeng Solife Holdings  (OTCPK:DOWAY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Defeng Solife Holdings Research & Development Related Terms

Defeng Solife Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Defeng Solife Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Defeng Solife Holdings Research & Development Chart

Defeng Solife Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Defeng Solife Holdings Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DOWAY
34GF Score
Defeng Solife Holdings Ltd DOWAY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Defeng Solife Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Defeng Solife Holdings (DOWAY) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Defeng Solife Holdings and its competitors.
Is Defeng Solife Holdings' Research & Development too high?
Defeng Solife Holdings' current Research & Development is $0.00 Mil. Overall, Defeng Solife Holdings has a GF Score™ of 34/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Defeng Solife Holdings' Research & Development compare to APP and OMC?
Defeng Solife Holdings' Research & Development of $0.00 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Media - Diversified company?
A good Research & Development depends on the Media - Diversified industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Defeng Solife Holdings and its competitors. Defeng Solife Holdings's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Defeng Solife Holdings stock overvalued right now?
Based on GuruFocus' analysis, Defeng Solife Holdings (DOWAY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.35, compared to a current price of $0.75 — trading 44.8% below its estimated fair value. The current Research & Development is $0.00 Mil. Defeng Solife Holdings' overall GF Score™ is 34/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Defeng Solife Holdings (DOWAY), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Defeng Solife Holdings (DOWAY) Overvalued in 2026?

Based on GuruFocus' analysis, Defeng Solife Holdings stock appears to be undervalued. The current stock price of $0.75 is trading 44.8% below its estimated GF Value™ of $1.35. GuruFocus considers Defeng Solife Holdings to be Possible Value Trap.

Key valuation signals for DOWAY:

  • Research & Development: $0.00 Mil
  • GF Value™: $1.35 vs. price of $0.75 (44.8% below fair value)
  • GF Score™: 34/100 with 8 warning signs

No single metric tells the full story. See the DOWAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Defeng Solife Holdings Business Description

Other Exchanges 08403:Hong Kong
Address No. 12 Dongdaqiao Road, Room No. 501-509, 5th Floor, Run Cheng Centre, Chaoyang District, Beijing, CHN, 100020
Defeng Solife Holdings Ltd is an integrated exhibition and event management services provider. The company engages in the design, planning, coordination, and management of exhibitions and events in the PRC. These services include design, planning, coordination, and management of exhibitions and events, covering theme, stage, and venue design and overall planning, feasibility studies, and procurement of construction materials and equipment. It has three operating segments that include the Exhibition and event-related business, E-commerce business, and the Advertising-related business. The majority of the revenue is generated from the Exhibition and event-related business segments.
34GF Score

Get the complete analysis for DOWAY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$1.35
GF Value